Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study

Grant

Date/time Interval

  • May 15, 2019 - December 31, 2020
  • Total Award Amount

  • 511575.00
  • Direct Costs

  • 344495.00
  • Sponsor Award Id

  • R01AG063689
  • Contributor

  • Bryan Smelser   Investigator  
  • David Geldmacher   Investigator  
  • Erik Roberson   Investigator  
  • Marissa Natelson Love   Principal Investigator  
  • Roberta May   Investigator